TRANSCAN
ERA-NET on Translational Cancer Research
| Coordinatore | MINISTERO DELLA SALUTE
Organization address
address: Via Giorgio Ribotta 5 contact info |
| Nazionalità Coordinatore | Italy [IT] |
| Sito del progetto | http://www.transcanfp7.eu/ |
| Totale costo | 2˙415˙483 € |
| EC contributo | 1˙999˙956 € |
| Programma | FP7-HEALTH
Specific Programme "Cooperation": Health |
| Code Call | FP7-ERANET-2010-RTD |
| Funding Scheme | CSA-CA |
| Anno di inizio | 2011 |
| Periodo (anno-mese-giorno) | 2011-01-01 - 2014-12-31 |
Partecipanti
| # | ||||
|---|---|---|---|---|
| 1 |
MINISTERO DELLA SALUTE
Organization address
address: Via Giorgio Ribotta 5 contact info |
IT (ROMA) | coordinator | 207˙825.00 |
| 2 |
ISTITUTO SUPERIORE DI SANITA
Organization address
address: Viale Regina Elena 299 contact info |
IT (ROMA) | participant | 396˙700.00 |
| 3 |
DEUTSCHES ZENTRUM FUER LUFT - UND RAUMFAHRT EV
Organization address
address: Linder Hoehe contact info |
DE (KOELN) | participant | 300˙357.00 |
| 4 |
INSTITUT NATIONAL DU CANCER
Organization address
city: Boulogne-Billancourt contact info |
FR (Boulogne-Billancourt) | participant | 269˙907.00 |
| 5 |
INSTITUTO DE SALUD CARLOS III
Organization address
address: CALLE SINESIO DELGADO 4-6 contact info |
ES (MADRID) | participant | 138˙386.00 |
| 6 |
ALLEANZA CONTRO IL CANCRO
Organization address
address: VIALE DELLA CIVILTA ROMANA 7 contact info |
IT (ROMA) | participant | 115˙560.00 |
| 7 |
CANCER RESEARCH UK
Organization address
address: ST JOHN STREET 407 ANGEL BUILDING contact info |
UK (LONDON) | participant | 111˙012.00 |
| 8 |
THE NETHERLANDS ORGANISATION FOR HEALTH RESEARCH AND DEVELOPMENT
Organization address
address: Laan Van Nieuw Oost Indie 334 contact info |
NL (DEN HAAG) | participant | 78˙377.00 |
| 9 |
FUNDACAO PARA A CIENCIA E A TECNOLOGIA
Organization address
address: AVENIDA D CARLOS I 126 contact info |
PT (LISBOA) | participant | 43˙870.00 |
| 10 |
MINISTRSTVO ZA VISOKO SOLSTVO, ZNANOST IN TEHNOLOGIJO
Organization address
address: Kotnikova 38 contact info |
SI (LJUBLJANA) | participant | 41˙730.00 |
| 11 |
LATVIJAS ZINATNU AKADEMIJA
Organization address
address: AKADEMIJAS LAUKUMS 1 contact info |
LV (RIGA) | participant | 33˙170.00 |
| 12 |
NORGES FORSKNINGSRAD
Organization address
address: Stensberggata 26 contact info |
NO (OSLO) | participant | 31˙256.00 |
| 13 |
KENTROU ELEGHOU & PROLIPSIS NOSIMATON
Organization address
address: AGRAFON 3-5 contact info |
EL (MAROUSI) | participant | 30˙805.00 |
| 14 |
GENIKI GRAMMATIA EREVNAS KAI TECHNOLOGIAS
Organization address
address: Mesogeion Avenue 14-18 contact info |
EL (ATHENS) | participant | 28˙890.00 |
| 15 |
SLOVENSKA AKADEMIA VIED
Organization address
address: Stefanikova, 49 contact info |
SK (BRATISLAVA) | participant | 26˙897.00 |
| 16 |
Nome Ente NON disponibile
Organization address
address: SENSENGASSE 1 contact info |
AT (WIEN) | participant | 24˙624.00 |
| 17 |
TURKIYE BILIMSEL VE TEKNOLOJIK ARASTIRMA KURUMU
Organization address
address: Ataturk Bulvari 221 contact info |
TR (ANKARA) | participant | 20˙062.00 |
| 18 |
Orszagos Onkologiai Intezet
Organization address
address: RATH GYORGY UTCA 7-9. contact info |
HU (Budapest) | participant | 19˙527.00 |
| 19 |
NARODOWE CENTRUM BADAN I ROZWOJU
Organization address
address: UL. NOWOGRODZKA 47A contact info |
PL (WARSZAWA) | participant | 16˙852.00 |
| 20 |
INSTITUTUL ONCOLOGIC PROF. DR. ALEXANDRU TRESTIOREANU BUCURESTI
Organization address
address: Soseaua Fundeni 5 contact info |
RO (BUCHAREST) | participant | 15˙515.00 |
| 21 |
MINISTRY OF HEALTH
Organization address
address: 2 Ben Tabai Street contact info |
IL (JERUSALEM) | participant | 15˙247.00 |
| 22 |
MINISTERO DELL'UNIVERSITA E DELLA RICERCA
Organization address
address: Via Michele Carcani 61 contact info |
IT (ROMA) | participant | 7˙000.00 |
| 23 |
MASARYKUV ONKOLOGICKY USTAV
Organization address
address: ZLUTY KOPEC 5 contact info |
CZ (BRNO) | participant | 6˙712.00 |
| 24 |
STICHTING KONINGIN WILHELMINA FONDS VOOR DE NEDERLANDSE KANKERBESTRIJDING
Organization address
address: DELFLANDLAAN 17 contact info |
NL (AMSTERDAM) | participant | 6˙675.00 |
| 25 |
FONDATION ARC POUR LA RECHERCHE SUR LE CANCER
Organization address
address: RUE GUY MOQUET 9 contact info |
FR (VILLEJUIF) | participant | 6˙500.00 |
| 26 |
Kreftforeningen
Organization address
address: TULLINS GATE 2 contact info |
NO (OSLO) | participant | 6˙500.00 |
| 27 |
BUNDESMINISTERIUM FUER BILDUNG UND FORSCHUNG
Organization address
address: Heinemannstrasse 2 contact info |
DE (BONN) | participant | 0.00 |
| 28 |
Ministrstvo za izobrazevanje, znanost in sport
Organization address
address: Masarykova 16 contact info |
SI (Ljubljana) | participant | 0.00 |
| 29 |
REGIONE LIGURIA
Organization address
address: VIA FIESCHI 15 contact info |
IT (GENOVA) | participant | 0.00 |
Mappa
Word cloud
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
Obiettivo del progetto (Objective)
'Cancer is a worldwide health burden and a major public health challenge in Europe, responsible for 25% of all deaths; a situation expected to worsen with population ageing. The strengthening of translational cancer research is an urgent need in European cancer research, i.e. the integration of basic, epidemiological, preclinical and clinical research with the implementation and evaluation of interventions in prevention, diagnosis, prognosis, treatment and care. The proposed ERA-NET TRANSCAN aims at linking translational cancer research funding programmes in 19 Member States and Associated Countries. By concentrating transnational resources TRANSCAN will provide a critical financial and scientific mass for tackling large scale problems, relevant for improving translational cancer research in each Member State or Associated Country as well as overall in Europe. The objectives of TRANSCAN will be achieved through interconnected activities, structured into six work packages (WP) and facilitated by the project coordination and management (WP1). A survey and analysis of national cancer research funding (WP2) will provide a comprehensive picture of the nature and extent of translational cancer research funding in the EU. Based on this knowledge, TRANSCAN will identify gaps in and opportunities for coordinated translational research, and will thus contribute to the development of a coordinated funding research policy shared by European countries. Based also on the outcome of these activities, three joint transnational calls for multinational translational cancer research programmes will be designed (WP3) and implemented (WP4). In this context, training programmes/activities of multi-disciplinary translational cancer research teams will be supported (WP5). The TRANSCAN performance will be monitored and confronted with the partners’ expectations, and a sustainability plan for the network beyond TRANSCAN will be elaborated (WP6), contributing to the building of a pan-European platform for translational cancer research.'